Promega HiBiT-PsVLP Bioassay enables simple, safe study without infectious viral particles. Assay supports collaboration between Charles River and CEPI’s Centralised Laboratory Network. Technology ...

Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...

A crucial step in drug development, bioassay development can take from three months to a year to accomplish. Time, personnel, and budget resources along with reagent, drug lot, and cell-line ...

Acquisition is the fourth for VION as it continues to expand its portfolio of proprietary products for life science research NASHVILLE, Tenn., February 05, 2025--(BUSINESS WIRE)--VION Biosciences, a ...

The National Institute for Occupational Safety and Health (NIOSH) is currently studying mortality in a large pooled cohort of uranium-enrichment workers. As part of this study, organ dose from chronic ...